Firocoxib sold under the brand names Equioxx and Previcox among others, is a

nonsteroidal anti-inflammatory drug Non-steroidal anti-inflammatory drugs (NSAID) are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever, and prevents blood clots. Side effects depend on the specific drug, its dose and duration of ...

of the

COX-2 inhibitor COX-2 inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, COX-2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX-2 reduces the risk of peptic ulceration and i ...

(coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox). Firocoxib is the first COX-2 inhibitor approved by the U.S.

Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food ...

for horses. Firocoxib is not intended or approved for use in human medicine.Equioxx
, European Medicines Agency Firocoxib was approved for veterinary use in the United States for dogs in July 2004, and for horses in July 2016. Firocoxib is available as a

generic medication A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active c ...

for horses and for dogs.

References

External links

* Dog medications Equine medications Furanones Benzosulfones COX-2 inhibitors Nonsteroidal anti-inflammatory drugs Ethers Cyclopropyl compounds {{musculoskeletal-drug-stub